Model Number U228 |
Device Problems
Over-Sensing (1438); Ambient Noise Problem (2877); Connection Problem (2900); Device Sensing Problem (2917)
|
Patient Problem
Syncope (1610)
|
Event Date 03/07/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
As no further information concerning this report is expected, our investigation is complete.
This investigation will be updated should further information be provided.
|
|
Event Description
|
Boston scientific received information that the patient implanted with this cardiac resynchronization therapy pacemaker (crt-p) and competitor leads experienced a syncopal episode.
Upon checking the device, instances of noise and oversensing were observed on both the right atrial (ra) and right ventricular (rv) leads though it was noted the recorded episode did not correspond to the time of the patient's syncope.
Boston scientific technical services (ts) discussed that without further information the cause of the patient's syncope nor noise could be conclusively determined.
Additional system testing was advised.
The patient subsequently underwent provocation testing at which time noise was recreated with bipolar sensing programmed.
An x-ray was then performed and the terminal pins of both leads could not be clearly visualized through the device header.
A revision procedure was then performed wherein the leads were reinserted into the header.
No additional adverse patient effects were reported.
This system remains in service.
|
|
Manufacturer Narrative
|
No further information has been provided to date.
This report will be updated should additional information become available.
|
|
Event Description
|
Additional information was received indicating intermittent episodes of noise and oversensing resulting in pacing inhibition continue to be observed.
It was noted there have been no fluctuations in lead impedance measurements and noise is difficult to reproduce.
Engineering level analysis determined the noise was likely not consistent with a device hardware issue.
Ts provided suggestions for additional assessment of the leads and programming options.
The device was programmed to fixed sensitivity.
Despite the periods of pacing inhibition the patient remains asymptomatic.
This system remains in service.
|
|
Manufacturer Narrative
|
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed.
A visual inspection of the device header and case noted no anomalies.
Pin gauge testing, designed to verify proper port dimensions, was completed.
Each port measured as expected.
The device was then exposed to simulated heart load conditions, and the pacing, and sensing functions were tested.
Impedance testing was completed and all measurements were within normal limits.
The device operated appropriately with no interruptions in therapy output at the returned programmed settings.
A series of electrical tests was also performed, and again, normal device function was observed.
|
|
Event Description
|
New information received indicates that the device was explanted and returned for analysis.
|
|
Search Alerts/Recalls
|